Tagged content
4 articles
In today’s global pharmaceutical environment, medicinal products are often developed, manufactured, marketed, and distributed across multiple countries and by several organizations. As a result, important safety information may…
Warnings National Medical Products Administration,China NMPA and the National Center for Adverse Drug Reaction Monitoring released the National Adverse Drug Reaction Monitoring Annual Report (2025). The report was published…
Warnings The FDA maintains a rigorous post-market surveillance system to protect public health through advanced Pharmacovigilance. Central to this is the FAERS (FDA Adverse Event Reporting System), a critical…
Trending topics In the current pediatric healthcare landscape, ensuring medication safety for children remains a critical challenge for global medical science. While adverse drug reactions (ADRs) are a major concern,…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP